RLS – Dopaminergic Augmentation — SCE Neurology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Gradually reduce ropinirole and transition to an alpha-2-delta ligand after iron assessment
This is dopamine-agonist augmentation. Avoid further dose escalation: assess and correct iron deficiency, taper the dopamine agonist and use a non-dopaminergic alternative such as an alpha-2-delta ligand where appropriate.
Reference: NICE CKS, Restless legs syndrome: https://cks.nice.org.uk/topics/restless-legs-syndrome/